Doxamed (formerly Loxamed) has been chosen by the Ile-de-France region to reinforce its screening policy and make it accessible to all Ile-de-France residents. The Ile-de-France region is facing a deteriorating health situation in its eight departments. An effective screening policy is an essential means of containing the circulation and spread of the virus.
Category : Press releases
COVID-19: THE ILE-DE-FRANCE REGIONAL HEALTH AGENCY VALIDATES LOXAMED'S HEALTH PROTOCOL
At a time when new outbreaks of contamination are raising fears of a resurgence in the COVID-19 epidemic, the Agence Régionale de Santé (ARS) Ile-de-France has issued a favorable opinion on LOXAMED's Mobile Diagnostic and Screening Unit, which will reinforce the control and fight against the epidemic.
OL presents its return to business and the "OL PROTEGE" scheme
Olympique Lyonnais would like to inform you that it will be resuming its activities on Monday June 8, within a very strict sanitary framework and with respect for the protection of employees' health, which is an absolute priority. The epidemic remains active and the virus is still circulating; it is everyone's responsibility to remain cautious and respect all barrier measures.
COVID-19: A PILOT OF MOBILE DIAGNOSTIC AND SCREENING UNITS IS LAUNCHED IN PARIS' 19TH DISTRICT TO SUPPORT THE DECONFINING PHASE
For over 15 days, a pilot mobile diagnostic and screening unit (UMDD) has been installed in front of a migrant workers' hostel in the 19th arrondissement. This innovative device, devised by LOXAM in partnership with AXAMED laboratories and the TELEDOK medical platform, will be deployed, at the request of the City of Paris, in all the capital's arrondissements to meet the needs of the city and its residents during the decontamination period.